Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Minority Interest
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Minority Interest Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
Minority Interest
HK$193.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Minority Interest
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Minority Interest
HK$162.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-4%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Minority Interest
¥11.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
18%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Minority Interest
HK$66B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Minority Interest
$13.3m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-3%
|
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
See Also
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Minority Interest?
Minority Interest
193.7m
HKD
Based on the financial report for Dec 31, 2025, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Minority Interest amounts to 193.7m HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Minority Interest growth rate?
Minority Interest CAGR 10Y
8%
Over the last year, the Minority Interest growth was 13%. The average annual Minority Interest growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been 13% over the past three years , 12% over the past five years , and 8% over the past ten years .
